肠道微生物群重塑TNBC免疫微环境:新兴的免疫治疗策略
Mingyao Huang1, Yikai Zhang1, Zhaoji Chen1
1School of Basic Medicine, Putian University, Putian, Fujian 351100, China.
Pharmacological research
|April 4, 2025
概括
肠道微生物群影响三阴性乳腺癌 (TNBC) 的进展和免疫治疗的有效性. 调节肠道微生物可能会改善TNBC治疗结果和患者预后.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 微生物学 微生物学
背景情况:
- 三阴性乳腺癌 (TNBC) 是具有有限治疗选择的侵袭性.
- 肠道微生物群通过肠-免疫轴关键调节免疫反应.
- 肠道微生物显著影响TNBC和免疫疗法的疗效.
研究的目的:
- 在TNBC中审查肠道微生物群与免疫系统的相互作用.
- 探索TNBC瘤免疫中的免疫细胞和途径.
- 检查微生物群调节策略,以增强免疫疗法.
主要方法:
- 关于肠道微生物群和TNBC的研究的文献综述.
- 免疫细胞在TNBC免疫中的作用和途径的分析.
- 对微生物群调制技术的评估.
主要成果:
- 肠道微生物群的组成会影响TNBC的进展.
- 肠免疫轴是TNBC瘤免疫的核心.
- 微生物群调节显示了改善免疫疗法的潜力.
结论:
- 了解肠道微生物群与免疫相互作用是TNBC的关键.
- 针对微生物群的疗法可能会提高TNBC治疗的疗效.
- 益生菌和FMT等策略为TNBC患者提供了新的途径.
更多相关视频
相关概念视频
02:17The Tumor Microenvironment
6.5K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.5K
01:27Tumor Immunotherapy
432
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
432
01:27Cytotoxic T Cells-mediated Immune Response
798
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
798
01:29Inflammatory Bowel Disease IV: Pharmacological Management
82
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
82
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
103
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
103